Table 5 Univariate regressions of patient characteristics and outcomes on EQ-5D scores; p-values significant at α < .05 shown in bold. Follow-up time in multiples of 30 day increments was defined as the number of days divided by 30 to approximate number of months

Age

 25 to 49 years

–

–

–

–

 50 to 64 years

−0.11

−0.22, 0.01

−4.7

−12, 2.2

 65 to 74 years

−0.11

− 0.22, 0.01

−5.9

−13, 1.1

 75 years and over

− 0.15

−0.28, − 0.03

− 5.7

− 13, 2.0

Sex

 Female

–

–

–

–

 Male

0.01

−0.05, 0.08

0.33

−3.6, 4.2

Cancer type

 Bowel

–

–

–

–

 Breast

0

−0.13, 0.12

− 0.99

−8.7, 6.8

 Lung

−0.02

−0.15, 0.11

−3.5

−11, 4.2

 Other

0.03

−0.08, 0.15

0.07

−7.1, 7.3

 Prostate

0.08

−0.07, 0.23

1.6

−7.7, 11

Cancer stage at baseline

 Living with condition

–

–

–

–

 Receiving palliative care

−0.08

−0.21, 0.06

−3.3

−11, 4.9

Recently completed treatment (within 1 month)

0.04

−0.12, 0.19

1.3

−8.2, 11

 Recently diagnosed (1 month)

0.08

−0.04, 0.20

−0.32

−7.7, 7.0

 Undergoing tests

0.21

0.05, 0.36

0.76

−8.5, 10

 Undergoing treatment

0.06

−0.04, 0.15

3

−2.6, 8.5

Cancer stage at follow-up

 Living with condition

–

–

–

–

 Receiving palliative care

−0.08

−0.18, 0.01

−9

−15, −3.5

Recently completed treatment (within 1 month)

− 0.03

− 0.15, 0.09

2.2

−4.9, 9.4

 Recently diagnosed (1 month)

−0.13

− 0.72, 0.45

−9.9

−45, 25

 Recurrence

0.45

−0.13, 1.0

−4.9

− 40, 30

 Undergoing tests

0.05

−0.15, 0.25

−11

−23, 1.2

 Undergoing treatment

−0.01

−0.09, 0.07

−2.8

−7.5, 2.0

Palliative care

 Yes

–

–

–

–

 No

0.09

0.01, 0.18

6.6

1.7, 12

Deprivation (1 = most deprived)

0

−0.01, 0.00

0.06

−0.34, 0.45

Number of concerns at baseline

0.02

0.00, 0.03

0.46

−0.37, 1.3

Mean change in concern severity at follow-up

−0.03

−0.04, − 0.02

−1.2

−1.9, − 0.39

Follow-up time (30 day increments)

0.02

0.01, 0.03

1.2

0.56, 1.9